Brett Howard
Senior Director, US Regulatory Policy U.S. Pharmacopeia
Brett Howard is a Senior Director of US Regulatory Policy at the US Pharmacopeia, where he manages USP’s regulatory efforts concerning pharmaceutical quality, covering both large and small molecules. Before joining USP, he spent the previous decade working for chemical and pharmaceutical trade associations, developing and implementing advocacy strategies related to chemical exposure, sustainability, nitrosamines, and microplastics, among others. Brett also spent several years as a patent litigator at a boutique IP firm in the DC area. He has a PhD in organic chemistry from UC Irvine (2009) and a JD from the University of Maryland (2012).
Seminars
Thursday 26th February 2026
Overcoming Global Regulatory Misalignment to Increase Efficiency in Viral Vector Manufacturing
2:15 pm
- Clarifying definitions of raw materials, starting materials, and ancillary components to enable global alignment and consistent quality expectations
- Discussing how industry and regulators can collaborate through pharmacopeial channels to anticipate evolving expectations
- Highlighting gaps and inconsistencies across regional guidance and how standardsetting organizations can help bridge interpretation differences
